{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: Furthermore , we identified a glycine to alanine substitution in the collagenous domain that is apparently silent in the heterozygous carriers , in 11 .\n\nLet's think step by step."},
    {"role": "assistant", "content": "The \"Disease\" entities in the paragraph are:\n\n1. Glycine to alanine substitution\n2. Heterozygous carriers\n3. Collagenous domain\n\nExplanation:\n\n1. Glycine to alanine substitution: This is a genetic mutation that occurs in the collagenous domain and is associated with a disease.\n2. Heterozygous carriers: These are individuals who carry the genetic mutation and are therefore susceptible to the disease.\n3. Collagenous domain: This is a region of a protein that is affected by the genetic mutation and is associated with the disease."},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "Sure, here are the entities that clearly refer to disease in the given paragraph:\n\n1. Glycine to alanine substitution\n2. Heterozygous carriers\n\nThe entity \"collagenous domain\" is not directly related to disease, so it can be removed from the list of disease entities."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here are the valid disease entities in a Markdown table:\n\n| Disease |\n| --- |\n| Glycine to alanine substitution |\n| Heterozygous carriers |"}
  ]
}